Tzanakis et al(37) demonstrated that a more marked expression of p53 was associated with a tumor size of >5 cm, and that advanced stage p53 expression was significantly decreased in poorly-differentiated adenocarcinoma compared with well- or moderately-differentiated adenocarcinoma, which is consistent with the present results. The gene discussed is TP53; the disease is adenocarcinoma.